foxo4-dri senolytic peptide 2024 study

foxo4-dri senolytic peptide 2024 study UK | Research Peptide inhibitors targeting FOXO4-p53 interactions

Name: foxo4-dri senolytic peptide 2024 study UK | Research Peptide inhibitors targeting FOXO4-p53 interactions
Brand: lcog.de
SKU: 25987172049
Price: 26.41 USD
Availability: InStock
Rating: 4.3393 (26 reviews)

Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv foxo4 dri peptide senolytic 2024 Wolverine BPC 157 5mg, TB 500 5mg (10mg Blend) High Purity, U.S. Made Research Peptides The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications FOXO4 DRI: The Senolytic Peptide That Targets Zombie Cells and Aging Revolution Health & Wellness foxo4 dri peptide senolytic 2024 Wolverine BPC 157 5mg, TB 500 5mg (10mg Blend) High Purity

SKU: 25987172049 · From lcog.de

4.3

USD26.41 USD48.41

Pay in 4 interest-free payments of $6.60 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

Description

DSIP has been studied for various potential physiological roles, including: Stress response and adaptation Pain modulation Immune system regulation Antioxidant properties Effects on endocrine function DSIP has been investigated for potential applications in sleep disorders, pain management, and substance withdrawal syndromes